1554060673872760832

Gamida Cell announced U.S. FDA accepted with #PriorityReview the Company’s BLA for #omidubicel as a treatment for patients with blood cancers in need of an allogeneic stem cell transplant.

PDUFA date: Jan 30, 2023

Learn More https://t.co/W30rsY0X3z https://t.co/OupUAO7zyV

Send us a message